Journal: Clinical and Translational Radiation Oncology ISSN (E) 2405-6308 ISSN (L) 2405-6308
Publisher: (2674) Elsevier (Alias: Elsevier, Elsevier BV, Elsevier Ltd, Elsevier Inc., Elsevier Masson, Elsevier Australia, Elsevier Ltd., Elsevier BV * North-Holland, Elsevier Doyma, Elsevier Editora Ltda, Elsevier Espana, Elsevier France * Editions Scientifiques et Medicales, Elsevier GmbH, Elsevier GmbH - Urban und Fischer, Elsevier Health Sciences, Elsevier Ireland Ltd., Elsevier Japan KK, Elsevier Oncology, Elsevier Science Publishers Ltd., Elsevier S.A., Pergamon Press)

There are no additional documents for this Publisher/Journal.

Item Type:	Journal/Series
Publication Type:	Journal
Refereed:	Yes
OA Permissions:	Article Version Allowed Embargo S/R Policy Id Conditions License Copyright Owner Accepted Manuscript Yes 2252 Published source must be acknowledged Must link to publisher version with DOI CC BY Accepted Manuscript Yes 2252 Published source must be acknowledged Must link to publisher version with DOI CC BY-NC-ND Published PDF Yes 2252 Published source must be acknowledged Must link to publisher version with DOI CC BY Published PDF Yes 2252 CC BY, CC BY-NC-ND Published PDF Yes 2252 Published source must be acknowledged Must link to publisher version with DOI CC BY-NC-ND
DOAJ:	Yes, journal is listed in DOAJ
OA since:	2016
Additional Information:	CC BY-NC-ND 4.0
CTA Excerpt:	ctRO is an open access journal publishing
Comment:	ctRO is an open access journal publishing research in clinical and translational radiation oncology. Furthering ESTRO’s mission to foster the role of radiation oncology to improve the care of patients with cancer, the journal offers the radiation oncology community a rapid route for the publication of original research, reviews, short communications and correspondence which cover all aspects of experimental radiobiology, clinical interventions and treatments. The Editors-in-Chief of ctRO, Pierre Blanchard (France) and Daniel Zips (Germany), ensure that all manuscripts are peer-reviewed rigorously and rapidly, with the assistance of an internationally respected Editorial Board. ctRO is an open access journal. Upon acceptance of a paper, the authors will be asked to meet the cost of publication through an article publication fee. The paper will be published open access following payment of the fee. All members of ESTRO are eligible for a discounted fee. The Editors-in-Chief and Editorial Board invite you to submit your work today!
URL:	URL URL Type https://doaj.org/toc/2405-6308 DOAJ http://www.elsevier.com/editors/perk/plagiarism-detection Plagiarism Detection https://www.elsevier.com/journals/clinical-and-translational-radiation-oncology/2405-6308/open-access-journal APC https://www.elsevier.com/journals/clinical-and-translational-radiation-oncology/2405-6308/guide-for-authors Blind peer review https://www.journals.elsevier.com/clinical-and-translational-radiation-oncology Journal Homepage http://www.elsevier.com/about/corporate-responsibility/research-4-life/research-4-life-programs Waiver Policy https://www.journals.elsevier.com/clinical-and-translational-radiation-oncology/editorial-board Editorial Board https://www.elsevier.com/about/policies/copyright Copyright https://www.elsevier.com/about/open-science/open-access Open Access
Conflict:	No
Refereed Source:	Ulrichsweb
Sherpa Romeo Id:	40017
Divisions:	04 Faculty of Medicine > University Hospital Zurich > Clinic for Radiation Oncology
License:	["licenses_typename_cc_by4, cc_by_nc_nd4" not defined]
Article Processing Charge(s):	Fee Currency Date 1494 EUR 2020 1530 EUR 2022
R&P Contract available?:	Yes
R&P Contract Details:	Contract Name/Title Period of validity Contract ID or number URL of web page ScienceDirect 01.01.2020 - 31.12.2020 Elsevier2020 ScienceDirect 01.01.2021 - 31.12.2021 Elsevier2021 ScienceDirect 01.01.2022 - 31.12.2022 Elsevier2022
Date Deposited:	20 Mar 2020 15:49
Last Modified:	29 Nov 2022 01:18
URI:	https://www.jdb.uzh.ch/id/eprint/43160